Loading clinical trials...

Selective Bilateral Laryngeal Reinnervation as a Secondary Treatment in Case of Bilateral Vocal Fold Paralysis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02400008

Selective Bilateral Laryngeal Reinnervation as a Secondary Treatment in Case of Bilateral Vocal Fold Paralysis

Selective laryngeal bilateral reinnervation as a secondary treatment in patients with bilateral vocal fold paralysis, previously treated by endoscopy, without residual arytenoids ankylosis. The surgi...

Lead sponsor: University Hospital, Rouen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATEDNA

Laryngeal Pacing Study

NCT03085316 · Bilateral Vocal Fold Paralysis (BVFP)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 22, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment4

Start dateNov 2014

Last updatedJan 22, 2026

Condition

Bilateral Vocal Fold Paralysis

Locations shown

Rouen University Hospital

Rouen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 22, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions